GSA Capital Partners LLP Has $2.89 Million Stock Holdings in Humana Inc. (NYSE:HUM)

GSA Capital Partners LLP lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 248.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,120 shares of the insurance provider's stock after purchasing an additional 6,504 shares during the period. GSA Capital Partners LLP's holdings in Humana were worth $2,889,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Pzena Investment Management LLC lifted its position in Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock worth $866,250,000 after acquiring an additional 1,955,375 shares during the last quarter. Davis Selected Advisers increased its holdings in shares of Humana by 16.1% during the 2nd quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider's stock worth $863,640,000 after purchasing an additional 321,233 shares during the period. Marshall Wace LLP increased its holdings in shares of Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock worth $532,564,000 after purchasing an additional 774,085 shares during the period. Legal & General Group Plc increased its holdings in shares of Humana by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider's stock worth $442,396,000 after purchasing an additional 24,842 shares during the period. Finally, Ontario Teachers Pension Plan Board increased its holdings in shares of Humana by 11,647.2% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider's stock worth $367,342,000 after purchasing an additional 1,050,459 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Ratings Changes

A number of research firms recently weighed in on HUM. TD Cowen upped their target price on shares of Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Sanford C. Bernstein raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price on the stock in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Humana from $349.00 to $250.00 and set a "hold" rating on the stock in a research note on Thursday, October 3rd. Wells Fargo & Company lowered their target price on shares of Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a research note on Monday, November 4th. Finally, Leerink Partners cut shares of Humana from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $315.86.

Humana Stock Down 0.8 %

Humana stock traded down $2.38 during mid-day trading on Tuesday, reaching $280.06. The company's stock had a trading volume of 1,600,041 shares, compared to its average volume of 1,872,915. The company has a market capitalization of $33.72 billion, a price-to-earnings ratio of 25.02, a price-to-earnings-growth ratio of 2.28 and a beta of 0.52. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The business's 50 day simple moving average is $287.94 and its 200 day simple moving average is $332.62. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, research analysts anticipate that Humana Inc. will post 15.83 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's dividend payout ratio is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.